RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
RecruitingNCT01719055
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
Brief summary (from the registry)
To compile characteristics of real-world clinical outcomes for Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice, when used according to the applicable Instructions for Use \- and - To evaluate the economic value and technical performance of Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice
Study details
- Official title
- A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
- Conditions
- Interventions
- Device: neurostimulation system
- Sponsor
- Boston Scientific Corporation
- Start date
- 2012-11-19
- Primary completion
- 2035-05
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Argentina, Australia, Belgium, Canada, Colombia, Denmark, Germany, Israel, Italy, Japan, Netherlands, Spain, Sweden, Switzerland, United Kingdom, United States
- Total sites listed
- 118
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Key Inclusion Criteria: * Study candidate is scheduled to be trialed, on-label, with a commercially approved Boston Scientific neurostimulation system for pain, per local directions for use * Signed a valid, IRB/EC-approved informed consent form * 18 years of age or older Key Exclusion Criteria: * Contraindicated for Boston Scientific neurostimulation system * Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or to complete study assessments
Canadian sites (3)
| Facility | City | Province |
|---|---|---|
| London Health Sciences Centre | London | |
| Hopital de Enfant-Jesus | Québec | |
| Regina General Hospital | Regina |
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01719055